Limited contribution of rare, noncoding variation to autism spectrum disorder from sequencing of 2,076 genomes in quartet families
Authors:
- Donna M. WerlingDWDonna M. Werling
- Harrison BrandHBHarrison Brand
- Joon-Yong AnJAJoon-Yong An
- Matthew R. StoneMSMatthew R. Stone
- Joseph T. GlessnerJGJoseph T. Glessner
- Lingxue ZhuLZLingxue Zhu
- Ryan L. CollinsRCRyan L. Collins
- Shan DongSDShan Dong
- Ryan M. LayerRLRyan M. Layer
- Eiriene-Chloe Markenscoff-PapadimitriouEMEiriene-Chloe Markenscoff-Papadimitriou
- Andrew FarrellAFAndrew Farrell
- Grace B. SchwartzGSGrace B. Schwartz
Preprint
Abstract
Summary: Genomic studies to date in autism spectrum disorder (ASD) have largely focused on newly arising mutations that disrupt protein coding sequence and strongly influence risk. We evaluate the contribution of noncoding regulatory variation across the size and frequency spectrum through whole genome sequencing of 519 ASD cases, their unaffected sibling controls, and parents. Cases carry a small excess of de novo (1.02-fold) noncoding variants, which is not significant after correcting for paternal age. Assessing 51,801 regulatory classes, no category is significantly associated with ASD after correction for multiple testing. The strongest signals are observed in coding regions, including structural variation not detected by previous technologies and missense variation. While rare noncoding variation likely contributes to risk in neurodevelopmental disorders, no category of variation has impact equivalent to loss-of-function mutations. Average effect sizes are likely to be smaller than that for coding variation, requiring substantially larger samples to quantify this risk.Keywords
This publication has 68 references indexed in Scilit:
- Rate of de novo mutations and the importance of father’s age to disease riskNature, 2012
- Sporadic autism exomes reveal a highly interconnected protein network of de novo mutationsNature, 2012
- De novo mutations revealed by whole-exome sequencing are strongly associated with autismNature, 2012
- De Novo Gene Disruptions in Children on the Autistic SpectrumNeuron, 2012
- Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic BoundariesCell, 2012
- A copy number variation morbidity map of developmental delayNature Genetics, 2011
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and AutismCell, 2011
- Functional impact of global rare copy number variation in autism spectrum disordersNature, 2010
- ChIP-seq accurately predicts tissue-specific activity of enhancersNature, 2009
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based studyThe Lancet, 2009